Nanomedicine Living Lab opens
1 November 2017
A living lab is a facility where products can be tested in the development phase under realistic conditions. Seven public and private parties will bring their facilities and expertise to the Nanomedicine Living Lab: Radboud University, Radboudumc, FutureChemistry, Mercurna, Cytofind Diagnostics, In Situ Insights and Pharmacytics. This regional network will continue to expand throughout the duration of the project because parties outside the consortium can also use the living lab.
Nanotechnology can help researchers make ‘smart’ adjustments that optimise the effects of drugs. For example, it can help ensure that the active substance can bind more selectively, that it can be transported to the right place in the body or that the drug can be made more perceptible in the body. This type of molecular modification of various drugs will be researched and tested at the Nanomedicine Living Lab. Because these new techniques and the necessary analytical equipment will also be accessible to third parties, the living lab will stimulate innovation at the intersection of drug development and nanotechnology.
Source: Radboud University